Cargando…
Docetaxel-loaded solid lipid nanoparticles prevent tumor growth and lung metastasis of 4T1 murine mammary carcinoma cells
BACKGROUND: Metastasis causes the most breast cancer-related deaths in women. Here, we investigated the antitumor effect of solid lipid nanoparticles (SLN-DTX) when used in the treatment of metastatic breast tumors using 4T1-bearing BALB/c mice. RESULTS: Solid lipid nanoparticles (SLNs) were produce...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7068958/ https://www.ncbi.nlm.nih.gov/pubmed/32164731 http://dx.doi.org/10.1186/s12951-020-00604-7 |
_version_ | 1783505680454385664 |
---|---|
author | da Rocha, Márcia Cristina Oliveira da Silva, Patrícia Bento Radicchi, Marina Arantes Andrade, Bárbara Yasmin Garcia de Oliveira, Jaqueline Vaz Venus, Tom Merker, Carolin Estrela-Lopis, Irina Longo, João Paulo Figueiró Báo, Sônia Nair |
author_facet | da Rocha, Márcia Cristina Oliveira da Silva, Patrícia Bento Radicchi, Marina Arantes Andrade, Bárbara Yasmin Garcia de Oliveira, Jaqueline Vaz Venus, Tom Merker, Carolin Estrela-Lopis, Irina Longo, João Paulo Figueiró Báo, Sônia Nair |
author_sort | da Rocha, Márcia Cristina Oliveira |
collection | PubMed |
description | BACKGROUND: Metastasis causes the most breast cancer-related deaths in women. Here, we investigated the antitumor effect of solid lipid nanoparticles (SLN-DTX) when used in the treatment of metastatic breast tumors using 4T1-bearing BALB/c mice. RESULTS: Solid lipid nanoparticles (SLNs) were produced using the high-energy method. Compritol 888 ATO was selected as the lipid matrix, and Pluronic F127 and Span 80 as the surfactants to stabilize nanoparticle dispersion. The particles had high stability for at least 120 days. The SLNs’ dispersion size was 128 nm, their polydispersity index (PDI) was 0.2, and they showed a negative zeta potential. SLNs had high docetaxel (DTX) entrapment efficiency (86%), 2% of drug loading and showed a controlled drug-release profile. The half-maximal inhibitory concentration (IC(50)) of SLN-DTX against 4T1 cells was more than 100 times lower than that of free DTX after 24 h treatment. In the cellular uptake test, SLN-DTX was taken into the cells significantly more than free DTX. The accumulation in the G2-M phase was significantly higher in cells treated with SLN-DTX (73.7%) than in cells treated with free DTX (23.0%), which induced subsequent apoptosis. TEM analysis revealed that SLN-DTX internalization is mediated by endocytosis, and fluorescence microscopy showed DTX induced microtubule damage. In vivo studies showed that SLN-DTX compared to free docetaxel exhibited higher antitumor efficacy by reducing tumor volume (p < 0.0001) and also prevented spontaneous lung metastasis in 4T1 tumor-bearing mice. Histological studies of lungs confirmed that treatment with SLN-DTX was able to prevent tumor. IL-6 serum levels, ki-67 and BCL-2 expression were analyzed and showed a remarkably strong reduction when used in a combined treatment. CONCLUSIONS: These results indicate that DTX-loaded SLNs may be a promising carrier to treat breast cancer and in metastasis prevention. [Image: see text] |
format | Online Article Text |
id | pubmed-7068958 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-70689582020-03-18 Docetaxel-loaded solid lipid nanoparticles prevent tumor growth and lung metastasis of 4T1 murine mammary carcinoma cells da Rocha, Márcia Cristina Oliveira da Silva, Patrícia Bento Radicchi, Marina Arantes Andrade, Bárbara Yasmin Garcia de Oliveira, Jaqueline Vaz Venus, Tom Merker, Carolin Estrela-Lopis, Irina Longo, João Paulo Figueiró Báo, Sônia Nair J Nanobiotechnology Research BACKGROUND: Metastasis causes the most breast cancer-related deaths in women. Here, we investigated the antitumor effect of solid lipid nanoparticles (SLN-DTX) when used in the treatment of metastatic breast tumors using 4T1-bearing BALB/c mice. RESULTS: Solid lipid nanoparticles (SLNs) were produced using the high-energy method. Compritol 888 ATO was selected as the lipid matrix, and Pluronic F127 and Span 80 as the surfactants to stabilize nanoparticle dispersion. The particles had high stability for at least 120 days. The SLNs’ dispersion size was 128 nm, their polydispersity index (PDI) was 0.2, and they showed a negative zeta potential. SLNs had high docetaxel (DTX) entrapment efficiency (86%), 2% of drug loading and showed a controlled drug-release profile. The half-maximal inhibitory concentration (IC(50)) of SLN-DTX against 4T1 cells was more than 100 times lower than that of free DTX after 24 h treatment. In the cellular uptake test, SLN-DTX was taken into the cells significantly more than free DTX. The accumulation in the G2-M phase was significantly higher in cells treated with SLN-DTX (73.7%) than in cells treated with free DTX (23.0%), which induced subsequent apoptosis. TEM analysis revealed that SLN-DTX internalization is mediated by endocytosis, and fluorescence microscopy showed DTX induced microtubule damage. In vivo studies showed that SLN-DTX compared to free docetaxel exhibited higher antitumor efficacy by reducing tumor volume (p < 0.0001) and also prevented spontaneous lung metastasis in 4T1 tumor-bearing mice. Histological studies of lungs confirmed that treatment with SLN-DTX was able to prevent tumor. IL-6 serum levels, ki-67 and BCL-2 expression were analyzed and showed a remarkably strong reduction when used in a combined treatment. CONCLUSIONS: These results indicate that DTX-loaded SLNs may be a promising carrier to treat breast cancer and in metastasis prevention. [Image: see text] BioMed Central 2020-03-12 /pmc/articles/PMC7068958/ /pubmed/32164731 http://dx.doi.org/10.1186/s12951-020-00604-7 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research da Rocha, Márcia Cristina Oliveira da Silva, Patrícia Bento Radicchi, Marina Arantes Andrade, Bárbara Yasmin Garcia de Oliveira, Jaqueline Vaz Venus, Tom Merker, Carolin Estrela-Lopis, Irina Longo, João Paulo Figueiró Báo, Sônia Nair Docetaxel-loaded solid lipid nanoparticles prevent tumor growth and lung metastasis of 4T1 murine mammary carcinoma cells |
title | Docetaxel-loaded solid lipid nanoparticles prevent tumor growth and lung metastasis of 4T1 murine mammary carcinoma cells |
title_full | Docetaxel-loaded solid lipid nanoparticles prevent tumor growth and lung metastasis of 4T1 murine mammary carcinoma cells |
title_fullStr | Docetaxel-loaded solid lipid nanoparticles prevent tumor growth and lung metastasis of 4T1 murine mammary carcinoma cells |
title_full_unstemmed | Docetaxel-loaded solid lipid nanoparticles prevent tumor growth and lung metastasis of 4T1 murine mammary carcinoma cells |
title_short | Docetaxel-loaded solid lipid nanoparticles prevent tumor growth and lung metastasis of 4T1 murine mammary carcinoma cells |
title_sort | docetaxel-loaded solid lipid nanoparticles prevent tumor growth and lung metastasis of 4t1 murine mammary carcinoma cells |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7068958/ https://www.ncbi.nlm.nih.gov/pubmed/32164731 http://dx.doi.org/10.1186/s12951-020-00604-7 |
work_keys_str_mv | AT darochamarciacristinaoliveira docetaxelloadedsolidlipidnanoparticlespreventtumorgrowthandlungmetastasisof4t1murinemammarycarcinomacells AT dasilvapatriciabento docetaxelloadedsolidlipidnanoparticlespreventtumorgrowthandlungmetastasisof4t1murinemammarycarcinomacells AT radicchimarinaarantes docetaxelloadedsolidlipidnanoparticlespreventtumorgrowthandlungmetastasisof4t1murinemammarycarcinomacells AT andradebarbarayasmingarcia docetaxelloadedsolidlipidnanoparticlespreventtumorgrowthandlungmetastasisof4t1murinemammarycarcinomacells AT deoliveirajaquelinevaz docetaxelloadedsolidlipidnanoparticlespreventtumorgrowthandlungmetastasisof4t1murinemammarycarcinomacells AT venustom docetaxelloadedsolidlipidnanoparticlespreventtumorgrowthandlungmetastasisof4t1murinemammarycarcinomacells AT merkercarolin docetaxelloadedsolidlipidnanoparticlespreventtumorgrowthandlungmetastasisof4t1murinemammarycarcinomacells AT estrelalopisirina docetaxelloadedsolidlipidnanoparticlespreventtumorgrowthandlungmetastasisof4t1murinemammarycarcinomacells AT longojoaopaulofigueiro docetaxelloadedsolidlipidnanoparticlespreventtumorgrowthandlungmetastasisof4t1murinemammarycarcinomacells AT baosonianair docetaxelloadedsolidlipidnanoparticlespreventtumorgrowthandlungmetastasisof4t1murinemammarycarcinomacells |